1-2 of 2
Jiali Lu
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

EX103, a Newly Re-Designed CD20×CD3 Molecule, Induces High Response in Heavily Pretreated Relapsed/Refractory (R/R) Patients with B-Cell Non-Hodgkin Lymphoma (B-NHL)

Mingyuan Sun, Lugui Qiu, Keshu Zhou, Kai Hu, Chunkang Chang, Dong Wu, Zhenling Li, Ming Gong, Wenjun Zhang, Daniel Yang, Jiali Lu, Junyuan Qi
Journal: Blood
Blood (2024) 144 (Supplement 1): 3103.
https://doi.org/10.1182/blood-2024-193606
Published: 2024
Journal Articles

EX103, a Novel CD20xCD3 Bispecific Antibody, Showed a Favorable Safety and Potent Single-Agent Antitumor Activity in Heavily Pretreated Relapsed/Refractory Patients with B-Cell Non-Hodgkin Lymphoma

Junyuan Qi, Mingyuan Sun, Keshu Zhou, Chunyan Ji, Fei Lu, Chunkang Chang, Wenjun Zhang, Daniel Yang, Jiali Lu, Jisen Li, Ying Cheng, Yanfei Li
Journal: Blood
Blood (2023) 142 (Supplement 1): 6230.
https://doi.org/10.1182/blood-2023-173486
Published: 2023